Corroborating the results above, our IHC data demonstrated that tissues from TNBC patients concurrently overexpressed CDH11 and β-catenin proteins, compared to the weak/non-expression in non-tumor tissues (Figure 2D–F). The gene discussed is CDH11; the disease is neoplasm.